Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

Related Articles by Review for PubMed (Select 19152690)

1.

Facts, values, and attention-deficit hyperactivity disorder (ADHD): an update on the controversies.

Parens E, Johnston J.

Child Adolesc Psychiatry Ment Health. 2009 Jan 19;3(1):1. doi: 10.1186/1753-2000-3-1.

2.

Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).

[No authors listed]

NIH Consens Statement. 1998 Nov 16-18;16(2):1-37. Review.

PMID:
10868163
3.

[Hearing impairment and psychopathological disorders in children and adolescents. Review of the recent literature].

Bailly D, Dechoulydelenclave MB, Lauwerier L.

Encephale. 2003 Jul-Aug;29(4 Pt 1):329-37. Review. French.

PMID:
14615703
5.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
6.

[Symptom variations in ADHD: importance of context, development and comorbidity].

Purper-Ouakil D, Wohl M, Michel G, Mouren MC, Gorwood P.

Encephale. 2004 Nov-Dec;30(6):533-9. Review. French.

PMID:
15738855
7.

Special considerations in diagnosing and treating attention-deficit/hyperactivity disorder.

Wigal SB, Wigal TL.

CNS Spectr. 2007 Jun;12(6 Suppl 9):1-14; quiz 15-6. Review.

PMID:
17545959
8.

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.

Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML; American Academy of Pediatrics Committee on Quality Improvement; American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.

Pediatrics. 2005 Jun;115(6):e749-57. Review.

PMID:
15930203
9.

The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder.

Sergeant J.

Neurosci Biobehav Rev. 2000 Jan;24(1):7-12. Review.

PMID:
10654654
10.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
11.
12.

[ADHD and attachment processes: are they related?].

Franc N, Maury M, Purper-Ouakil D.

Encephale. 2009 Jun;35(3):256-61. doi: 10.1016/j.encep.2008.04.007. Epub 2008 Sep 20. Review. French.

PMID:
19540412
13.
14.

Adaptive changes related to medication treatment of ADHD: listening to parents of children in clinical trials of a novel nonstimulant medication.

Saylor KE, Buermeyer CM, Spencer TJ, Barkley RA.

J Clin Psychiatry. 2002;63 Suppl 12:23-8. Review.

PMID:
12562058
15.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
16.

Attention deficit hyperactivity disorder: a review of the essential facts.

Daley D.

Child Care Health Dev. 2006 Mar;32(2):193-204. Review.

PMID:
16441854
17.

A systematic review of parenting in relation to the development of comorbidities and functional impairments in children with attention-deficit/hyperactivity disorder (ADHD).

Deault LC.

Child Psychiatry Hum Dev. 2010 Apr;41(2):168-92. doi: 10.1007/s10578-009-0159-4. Epub 2009 Sep 19. Review.

PMID:
19768532
18.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
19.
20.

Treatment of attention-deficit hyperactivity disorder.

Murray L, Patel DR.

Indian J Pediatr. 2001 Jan;68(1):1-9. Review.

PMID:
11237228
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk